The University of Nottingham is a public research university in Nottingham, United Kingdom. It was founded as University College Nottingham in 1881, and was granted a royal charter in 1948. The University of Nottingham belongs to the elite research intensive Russell Group association.

During the past decade, University of Nottingham conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 8 clinical trials were completed, i.e. on average, 13.1% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 7 clinical trials were completed. i.e. 21.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Nottingham" #1 sponsor was "University of Nottingham" with 71 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored, "Biosite" with 1 trials sponsored and "Cook Group Incorporated" with 1 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nottingham" #1 collaborator was "National Institute for Health Research, United Kingdom" with 6 trials as a collaborator, "University of Nottingham" with 6 trials as a collaborator, "Nottingham University Hospitals NHS Trust" with 5 trials as a collaborator, "King's College London" with 4 trials as a collaborator and "Mars, Inc." with 3 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "University of Nottingham" are "Constipation" (5 trials), "Obesity" (5 trials), "Irritable Bowel Syndrome" (3 trials), "Pain" (3 trials) and "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "University of Nottingham" in a lesser frequency.

Most popular intervention types in "University of Nottingham" are "Other" (32 trials), "Drug" (20 trials), "Dietary Supplement" (13 trials), "Behavioral" (12 trials) and "Diagnostic Test" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Bisacodyl 5 milligram" (2 trials), "Infection with hookworm larvae" (2 trials), "Maltodextrin" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Nottingham" are 79 trials for "All" genders, 8 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University of Nottingham". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in University of Nottingham, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Nottingham, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 46 trials that are defined as “Not Applicable".

University of Nottingham has several departments that took part in Clinical trials: "Nottingham Digestive Diseases Centre" - 13 trials, "David Greenfield Human Physiology Unit" - 12 trials, "Academic Rheumatology" - 5 trials, "University of Nottingham, School of Medicine, Division of Medical Sciences and Graduate Entry Medicine" - 4 trials, "Clinical Neurology, Division of Clinical Neuroscience, University of Nottingham, UK" - 2 trials, "Pharmacy Department" - 2 trials